» Articles » PMID: 8856052

Conformational Study of [Met5]enkephalin-Arg-Phe in the Presence of Phosphatidylserine Vesicles

Overview
Journal Eur J Biochem
Specialty Biochemistry
Date 1996 Sep 15
PMID 8856052
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The interaction of [Met5]enkephalin-Arg.Phe with phosphatidylserine (PtdSer) was studied by circular dichroism (CD), two-dimensional nuclear magnetic resonance spectroscopy, hybrid distance geometry simulated annealing (DG-SA) and molecular dynamics (MD) calculations. The very low solubility of [Met5]enkephalin-Arg-Phe and the instability of the solution containing PtdSer vesicles at low pH values did not allow us to observe the amide proton resonances in the usual two-dimensional NMR work. NOESY cross-peaks of protons of side chains from two-dimensional NMR were converted into distances which were used as restraints for modelling with DG-SA and MD. Our results indicate that, in aqueous solutions at pH 7.68 [Met5]enkephalin-Arg-Phe exists in the absence of PtdSer as a random distribution of conformers, whereas in the presence of PtdSer it adopts conformations containing a common orientation of the bonds of C alpha 2, C alpha 3, C alpha 4, and C alpha 5, although different orientations of the peptide planes are consistent with the results. Two of the reported conformers from MD simulations are characterized by the presence of a 2<--4 gamma and inverse gamma turns centered on Gly3. A gradual decline of order was observed when moving from the central moiety of the peptide to both the N-terminus and C-terminus. Finally, the DG-SA and MD calculations resulted in a structure such that the orientation of the Phe4 and Met5 side chains favours hydrophobic interactions with the apolar portion of the PtdSer vesicle to form a hydrophobic cluster. These data support the hypothesis of a role of lipids to modify the conformation of [Met5]enkephalin-Arg-Phe to permit the interactions with the receptor site.

Citing Articles

Kinetics of binding and diffusivity of leucine-enkephalin in large unilamellar vesicle by pulsed-field-gradient H NMR .

Yoshii N, Emoto T, Okamura E Biophysics (Nagoya-shi). 2016; 7:105-111.

PMID: 27857598 PMC: 5036784. DOI: 10.2142/biophysics.7.105.


Effects of Leucin-Enkephalins on Surface Characteristics and Morphology of Model Membranes Composed of Raft-Forming Lipids.

Tsanova A, Jordanova A, Lalchev Z J Membr Biol. 2015; 249(3):229-38.

PMID: 26661722 DOI: 10.1007/s00232-015-9862-1.


Transition pathway and its free-energy profile: a protocol for protein folding simulations.

Lee I, Kim S, Lee J Int J Mol Sci. 2013; 14(8):16058-75.

PMID: 23917881 PMC: 3759899. DOI: 10.3390/ijms140816058.


Discovery of a potent and efficacious peptide derivative for δ/μ opioid agonist/neurokinin 1 antagonist activity with a 2',6'-dimethyl-L-tyrosine: in vitro, in vivo, and NMR-based structural studies.

Yamamoto T, Nair P, Largent-Milnes T, Jacobsen N, Davis P, Ma S J Med Chem. 2011; 54(7):2029-38.

PMID: 21366266 PMC: 3090346. DOI: 10.1021/jm101023r.


Biological and conformational evaluation of bifunctional compounds for opioid receptor agonists and neurokinin 1 receptor antagonists possessing two penicillamines.

Yamamoto T, Nair P, Jacobsen N, Kulkarni V, Davis P, Ma S J Med Chem. 2010; 53(15):5491-501.

PMID: 20617791 PMC: 2943425. DOI: 10.1021/jm100157m.